3D Bioprinting Market Global Forecast to 2030, Featuring EnvisionTEC, Organovo, Inventia Life Science, Poietis, Vivax Bio, Allevi, Cyfuse Biomedical, 3D Bioprinting Solutions & Cellink Glo...
Organovo Holdings, Inc. (ONVO)
NASDAQ:AMEX Investor Relations:
organovo.com/about/contact/investor-relations
Company Research
Source: Yahoo! Finance
The worldwide 3D bioprinting market was worth USD 2.0 billion in 2022, and it is predicted to increase at a compound annual growth rate (CAGR) of 20.4% between 2023 and 2030. The increase is attributable to a scarcity of organ donors and an ageing population with chronic respiratory disorders. Rising R&D expenditure, technological innovation, and an increase in the prevalence of chronic illnesses are all factors that are projected to drive market expansion. The 3D printing community reacted to the COVID-19 problem by volunteering to assist in the manufacturing of critical medical equipment for hospitals dealing with the epidemic. Key Takeaways This report illustrates the most vital attributes of the 3D Bioprinting Market, which are driving and providing opportunities. This research gives an in-depth analysis of the 3D Bioprinting Market growth on the basis of several segments in the market. This report presents the predictions of the past and present trends of the 3D Biop
Show less
Read more
Impact Snapshot
Event Time:
ONVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ONVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ONVO alerts
High impacting Organovo Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
ONVO
News
- Organovo Data Presented at Digestive Disease Week (DDW2024) Demonstrating Potential for FXR314 as Combination Therapy with Tofacitinib for Inflammatory Bowel DiseaseGlobeNewswire
- Organovo Holdings, Inc. (NASDAQ: ONVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Organovo to Present Data on FXR314 at Digestive Diseases Week (DDW2024) [Yahoo! Finance]Yahoo! Finance
- Organovo to Present Data on FXR314 at Digestive Diseases Week (DDW2024) [Financial Post (Toronto, Ontario, Canada)]Financial Post
- Organovo to Present Data on FXR314 at Digestive Diseases Week (DDW2024)GlobeNewswire
ONVO
Sec Filings
- 5/14/24 - Form 424B4
- 5/13/24 - Form 8-K
- 5/10/24 - Form 424B4
- ONVO's page on the SEC website